Status:
COMPLETED
Long Term Results of Combined Transpupillary Thermotherapy (TTT) Indocyanine Green (ICG) Based Photodynamic Therapy (PDT) in Choroidal Melanoma
Lead Sponsor:
New England Retina Associates
Conditions:
Choroidal Melanoma
Eligibility:
All Genders
18-95 years
Brief Summary
This is a report of 10 years results of combined Transpupillary thermotherapy (TTT) treatment with Indocyanine green (ICG) in controlling small and medium-sized choroidal melanomas.
Detailed Description
The study was done in a Clinical practice setting. Forty six eyes of 46 patients with small or medium-sized choroidal melanomas were treated with i-TTT using infrared light delivered from a diode lase...
Eligibility Criteria
Inclusion
- Small and medium-sized choroidal melanoma
- Patients older than 18 years old.
- Patients who can read and signed the informed consent.
Exclusion
- Patients with ocular inflammation.
- Patients with another active ocular disease.
Key Trial Info
Start Date :
January 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2009
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT01253759
Start Date
January 1 2009
End Date
March 1 2009
Last Update
May 3 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New England Retina Associates
Hamden, Connecticut, United States, 06518